Viking Therapeutics, Inc.

Viking Therapeutics, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. This stock has a reasonable momentum. Viking Therapeutics, Inc. is not very popular among insiders. Viking Therapeutics, Inc. is a mediocre stock to choose.
Log in to see more information.
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the develo...
VKTX Fundamental Data by TradingView

News

Why Viking Therapeutics Stock Rocked the Market Today
Why Viking Therapeutics Stock Rocked the Market Today

Fool.com Headlines Viking Therapeutics (NASDAQ: VKTX) stormed the stock market on Wednesday. Shares of the up-and-coming biotech rose by more than 11% not on any proprietary news from the company, but on an analyst's...\n more…

Viking Therapeutics initiated with bullish view at JPMorgan, here's why
Viking Therapeutics initiated with bullish view at JPMorgan, here's why

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Viking Therapeutics, Inc. (VKTX) Laps the Stock Market: Here's Why
Viking Therapeutics, Inc. (VKTX) Laps the Stock Market: Here's Why

Zacks Investment Research The latest trading session saw Viking Therapeutics, Inc. (VKTX) ending at $54.78, denoting a +1.2% adjustment from its last day's close. This move outpaced the S&P 500's daily gain of 1.16...\n more…

Viking Therapeutics's Options Frenzy: What You Need to Know
Viking Therapeutics's Options Frenzy: What You Need to Know

Benzinga High-rolling investors have positioned themselves bullish on Viking Therapeutics VKTX, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in VKTX often signals that someone has privileged information.\n more…

Companies Like Viking Therapeutics (NASDAQ:VKTX) Can Afford To Invest In Growth
Companies Like Viking Therapeutics (NASDAQ:VKTX) Can Afford To Invest In Growth

Simply Wall St Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...\n more…

Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead?
Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead?

Fool.com Headlines Wall Street investment banks keep pounding the table on Viking Therapeutics (NASDAQ: VKTX) and its weight loss drug candidate. Predictions vary, but the average analyst who follows the stock thinks...\n more…